About RenalGuard Solutions
RenalGuard Solutions is a company based in Milford (United States) founded in 1981. RenalGuard Solutions offers products and services including RenalPro Therapy. RenalGuard Solutions operates in a competitive market with competitors including On Target Laboratories, Guerbet, Osprey Medical, Solstice Pharmaceuticals and Cision Vision, among others.
- Headquarter Milford, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Renalguard Solutions, Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$14.5 M (USD), Post-IPO
Mar 16, 2017
-
Investors
Exigent Capital
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of RenalGuard Solutions
RenalGuard Solutions offers a comprehensive portfolio of products and services, including RenalPro Therapy.
Prevents Acute Kidney Injury by balancing IV fluids during procedures.
People of RenalGuard Solutions
Unlock access to complete
Unlock access to complete
Funding Insights of RenalGuard Solutions
Investors in RenalGuard Solutions
RenalGuard Solutions has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Exigent Capital and Genesis Capital Advisors.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Exigent Capital is engaged in diversified financial services.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for RenalGuard Solutions
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by RenalGuard Solutions
Investment portfolio details for RenalGuard Solutions
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - RenalGuard Solutions
Detailed financials for RenalGuard Solutions
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Renalguard Solutions Comparisons
Peer comparison for RenalGuard Solutions
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of RenalGuard Solutions
RenalGuard Solutions operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as On Target Laboratories, Guerbet, Osprey Medical, Solstice Pharmaceuticals and Cision Vision, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Molecular imaging agents for cancer surgery are developed.
|
|
| Locked | Locked | Locked |
Contrast agents and delivery systems are developed for medical imaging.
|
|
| Locked | Locked | Locked |
Technology to reduce contrast dye exposure
|
|
| Locked | Locked | Locked |
Ultrasound contrast agents are developed for diagnosing multiple diseases.
|
|
| Locked | Locked | Locked |
High contrast real-time imaging devices are developed for medical visualization.
|
Detailed competitors of RenalGuard Solutions
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Renalguard Solutions
Complete news archive for RenalGuard Solutions
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about RenalGuard Solutions
RenalGuard Solutions was founded in 1981 and raised its 1st funding round 30 years after it was founded.
RenalGuard Solutions is headquartered in Milford, United States.
Jim Dillon is the current CEO of RenalGuard Solutions.
RenalGuard Solutions, formerly known as PLC Medical, is a medical device company focused on technologies for the cardiac and vascular markets. Their lead product, RenalGuard, is CE-marked and is designed to remove contrast dyes that are toxic to the kidneys. Contrast dyes are used in many cardiovascular diagnostic and interventional imaging procedures to facilitate the capture and display of x-ray images. Radiocontrast agents are a type of medical contrast medium used to improve the visibility of internal bodily structures in X-ray-based imaging techniques such ascomputed tomography (CT), radiography, and fluoroscopy.
RenalGuard Solutions's top competitors include Guerbet, On Target Laboratories and Osprey Medical.
RenalGuard Solutions offers RenalPro Therapy.
RenalGuard Solutions has 2 investors. Key investors include Exigent Capital, and Genesis Capital Advisors.